79 results on '"Coopersmith, C."'
Search Results
2. A Multicenter Study on Deriving and Validating Data-driven Phenotypes for Sepsis-induced Acute Respiratory Failure in ICU Patients
- Author
-
Choudhary, T., primary, Upadhyaya, P., additional, Davis, C., additional, Yang, P., additional, Coopersmith, C., additional, and Kamaleswarsan, R., additional
- Published
- 2024
- Full Text
- View/download PDF
3. Environmental and Social Determinants of Fever in COVID-19
- Author
-
Bhavani, S., primary, Edathara, N., additional, Lyons, P.G., additional, Luo, Y., additional, Wiley, Z., additional, Mao, C., additional, Bewley, A., additional, Robichaux, C., additional, Verhoef, P.A., additional, and Coopersmith, C., additional
- Published
- 2022
- Full Text
- View/download PDF
4. Surviving Sepsis Campaign Guidelines on the Management of Adults With Coronavirus Disease 2019 (COVID-19) in the ICU: First Update
- Author
-
Alhazzani, W, Evans, L, Alshamsi, F, Møller, M, Ostermann, M, Prescott, H, Arabi, Y, Loeb, M, Ng Gong, M, Fan, E, Oczkowski, S, Levy, M, Derde, L, Dzierba, A, Du, B, Machado, F, Wunsch, H, Crowther, M, Cecconi, M, Koh, Y, Burry, L, Chertow, D, Szczeklik, W, Belley-Cote, E, Greco, M, Bala, M, Zarychanski, R, Kesecioglu, J, Mcgeer, A, Mermel, L, Mammen, M, Nainan Myatra, S, Arrington, A, Kleinpell, R, Citerio, G, Lewis, K, Bridges, E, Memish, Z, Hammond, N, Hayden, F, Alshahrani, M, Al Duhailib, Z, Martin, G, Kaplan, L, Coopersmith, C, Antonelli, M, Rhodes, A, Alhazzani, Waleed, Evans, Laura, Alshamsi, Fayez, Møller, Morten Hylander, Ostermann, Marlies, Prescott, Hallie C., Arabi, Yaseen M., Loeb, Mark, Ng Gong, Michelle, Fan, Eddy, Oczkowski, Simon, Levy, Mitchell M., Derde, Lennie, Dzierba, Amy, Du, Bin, Machado, Flavia, Wunsch, Hannah, Crowther, Mark, Cecconi, Maurizio, Koh, Younsuck, Burry, Lisa, Chertow, Daniel S., Szczeklik, Wojciech, Belley-Cote, Emilie, Greco, Massimiliano, Bala, Malgorzata, Zarychanski, Ryan, Kesecioglu, Jozef, McGeer, Allison, Mermel, Leonard, Mammen, Manoj J., Nainan Myatra, Sheila, Arrington, Amy, Kleinpell, Ruth, Citerio, Giuseppe, Lewis, Kimberley, Bridges, Elizabeth, Memish, Ziad A., Hammond, Naomi, Hayden, Frederick G., Alshahrani, Muhammed, Al Duhailib, Zainab, Martin, Greg S., Kaplan, Lewis J., Coopersmith, Craig M., Antonelli, Massimo, Rhodes, Andrew, Alhazzani, W, Evans, L, Alshamsi, F, Møller, M, Ostermann, M, Prescott, H, Arabi, Y, Loeb, M, Ng Gong, M, Fan, E, Oczkowski, S, Levy, M, Derde, L, Dzierba, A, Du, B, Machado, F, Wunsch, H, Crowther, M, Cecconi, M, Koh, Y, Burry, L, Chertow, D, Szczeklik, W, Belley-Cote, E, Greco, M, Bala, M, Zarychanski, R, Kesecioglu, J, Mcgeer, A, Mermel, L, Mammen, M, Nainan Myatra, S, Arrington, A, Kleinpell, R, Citerio, G, Lewis, K, Bridges, E, Memish, Z, Hammond, N, Hayden, F, Alshahrani, M, Al Duhailib, Z, Martin, G, Kaplan, L, Coopersmith, C, Antonelli, M, Rhodes, A, Alhazzani, Waleed, Evans, Laura, Alshamsi, Fayez, Møller, Morten Hylander, Ostermann, Marlies, Prescott, Hallie C., Arabi, Yaseen M., Loeb, Mark, Ng Gong, Michelle, Fan, Eddy, Oczkowski, Simon, Levy, Mitchell M., Derde, Lennie, Dzierba, Amy, Du, Bin, Machado, Flavia, Wunsch, Hannah, Crowther, Mark, Cecconi, Maurizio, Koh, Younsuck, Burry, Lisa, Chertow, Daniel S., Szczeklik, Wojciech, Belley-Cote, Emilie, Greco, Massimiliano, Bala, Malgorzata, Zarychanski, Ryan, Kesecioglu, Jozef, McGeer, Allison, Mermel, Leonard, Mammen, Manoj J., Nainan Myatra, Sheila, Arrington, Amy, Kleinpell, Ruth, Citerio, Giuseppe, Lewis, Kimberley, Bridges, Elizabeth, Memish, Ziad A., Hammond, Naomi, Hayden, Frederick G., Alshahrani, Muhammed, Al Duhailib, Zainab, Martin, Greg S., Kaplan, Lewis J., Coopersmith, Craig M., Antonelli, Massimo, and Rhodes, Andrew
- Abstract
BACKGROUND: The coronavirus disease 2019 pandemic continues to affect millions worldwide. Given the rapidly growing evidence base, we implemented a living guideline model to provide guidance on the management of patients with severe or critical coronavirus disease 2019 in the ICU. METHODS: The Surviving Sepsis Campaign Coronavirus Disease 2019 panel has expanded to include 43 experts from 14 countries; all panel members completed an electronic conflict-of-interest disclosure form. In this update, the panel addressed nine questions relevant to managing severe or critical coronavirus disease 2019 in the ICU. We used the World Health Organization's definition of severe and critical coronavirus disease 2019. The systematic reviews team searched the literature for relevant evidence, aiming to identify systematic reviews and clinical trials. When appropriate, we performed a random-effects meta-analysis to summarize treatment effects. We assessed the quality of the evidence using the Grading of Recommendations, Assessment, Development, and Evaluation approach, then used the evidence-to-decision framework to generate recommendations based on the balance between benefit and harm, resource and cost implications, equity, and feasibility. RESULTS: The Surviving Sepsis Campaign Coronavirus Diease 2019 panel issued nine statements (three new and six updated) related to ICU patients with severe or critical coronavirus disease 2019. For severe or critical coronavirus disease 2019, the panel strongly recommends using systemic corticosteroids and venous thromboprophylaxis but strongly recommends against using hydroxychloroquine. In addition, the panel suggests using dexamethasone (compared with other corticosteroids) and suggests against using convalescent plasma and therapeutic anticoagulation outside clinical trials. The Surviving Sepsis Campaign Coronavirus Diease 2019 panel suggests using remdesivir in nonventilated patients with severe coronavirus disease 2019 and suggests again
- Published
- 2021
5. Body Temperature Trajectory Associated with Venous Thromboembolism in COVID-19 Patients
- Author
-
Bhavani, S., primary, Holder, A., additional, Kamaleswaran, R., additional, Verhoef, P.A., additional, Churpek, M.M., additional, Wang, M., additional, and Coopersmith, C., additional
- Published
- 2021
- Full Text
- View/download PDF
6. Renal transplantation following previous heart, liver, and lung transplantation: An 8-year single-center experience
- Author
-
Coopersmith, C. M., Brennan, D. C., Miller, B., Wang, C., Hmiel, P., Shenoy, S., Ramachandran, V., Jendrisak, M. D., Ceriotti, C. S., Mohanakumar, T., and Lowell, J. A.
- Published
- 2001
7. Genetic Predisposition in Sepsis: A Mechanisitic Approach in a Mouse Model of Pneumonia
- Author
-
Buckley, R., primary, Bucher, B., additional, Dunne, M., additional, Coopersmith, C., additional, and Cobb, J., additional
- Published
- 2010
- Full Text
- View/download PDF
8. 227. Genetic Predisposition to Sepsis: Strain Variance in a Mouse Model of Pneumonia
- Author
-
Bucher, B.T., primary, Fox, A., additional, Oppedal, D., additional, Davis, C., additional, Dunne, M., additional, Coopersmith, C., additional, Buchman, T.G., additional, Hotchkiss, R., additional, and Cobb, J.P., additional
- Published
- 2009
- Full Text
- View/download PDF
9. Improving extubation rates with daily spontaneous breathing trials
- Author
-
Sona, C., Schallom, L., Cracchiolo, L., Buckles, M., Song, F., Schuerer, D., Coopersmith, C., Buchman, P., and Robertson, T.
- Subjects
Intensive care units -- Services -- Analysis -- Methods ,Breath tests -- Methods -- Analysis ,Health ,Health care industry ,Analysis ,Services ,Methods - Abstract
Purpose: As part of a collaborative multicenter project, daily spontaneous breathing trials (SBTs) were implemented in our 24-bed surgical/trauma unit in a university-affiliated medical center. The purpose was to study [...]
- Published
- 2007
10. Mechanisms of epithelial resistance to Entamoeba histolytica-induced gut injury
- Author
-
Cho, K, primary, Hamano, S, additional, Becker, S, additional, Guo, X, additional, Stroup, S, additional, Coopersmith, C, additional, Leiter, E, additional, and Houpt, E, additional
- Published
- 2008
- Full Text
- View/download PDF
11. Mupirocin Resistance in Patients Colonized with Methicillin-Resistant Staphylococcus aureus in a Surgical Intensive Care Unit
- Author
-
Jones, J. C., primary, Rogers, T. J., additional, Brookmeyer, P., additional, Dunne, W. M., additional, Storch, G. A., additional, Coopersmith, C. M., additional, Fraser, V. J., additional, and Warren, D. K., additional
- Published
- 2007
- Full Text
- View/download PDF
12. GRAM POSITIVE AND GRAM NEGATIVE MURINE PNEUMONIA INDUCE UNIQUE LOCAL CYTOKINE PROFILES
- Author
-
McConnell, K., primary, Dunne, M., additional, Buchman, T., additional, Hotchkiss, R., additional, and Coopersmith, C., additional
- Published
- 2006
- Full Text
- View/download PDF
13. MODELING AGING AND SEPSIS
- Author
-
Turnbull, I., primary, Buchman, T., additional, and Coopersmith, C., additional
- Published
- 2006
- Full Text
- View/download PDF
14. AN EXAMINATION OF MECHANISMS UNDERLYING THE SURVIVAL BENEFIT CONFERRED BY INTESTINESPECIFIC OVEREXPRESSION OF INTERLEUKIN-10
- Author
-
Rajan, S., primary, Woolsey, C., additional, Buchman, T., additional, Hotchkiss, R., additional, and Coopersmith, C., additional
- Published
- 2006
- Full Text
- View/download PDF
15. INTESTINE SPECIFIC OVEREXPRESSION OF IL-10 IMPROVES SURVIVAL IN A POLYMICROBIAL MODEL OF SEPSIS.
- Author
-
Rajan, Saju, primary, Vyas, D, additional, Buchman, T G, additional, Coopersmith, C M, additional, and Hotchkiss, R S, additional
- Published
- 2005
- Full Text
- View/download PDF
16. THE ADAPTIVE IMMUNE SYSTEM MEDIATES GUT EPITHELIAL APOPTOSIS FOLLOWING CECAL LIGATION AND PUNCTURE
- Author
-
Woolsey, C A, primary, Stromberg, P E, additional, Javadi, P, additional, Husain, K D, additional, Chang, K C, additional, Hotchkiss, R S, additional, Karl, I E, additional, Buchman, T G, additional, and Coopersmith, C M, additional
- Published
- 2004
- Full Text
- View/download PDF
17. MICE EXPRESSING CASPASE-3 RESISTANT RETINOBLASTOMA PROTEIN HAVE DECREASED GUT EPITHELIAL BUT NOT SPLENIC APOPTOSIS IN PSEUDOMONAS AERUGINOSA PNEUMONIA
- Author
-
Stromberg, P E, primary, Woolsey, C A, additional, Husain, K D, additional, Dunne, W M, additional, Buchman, T G, additional, Karl, I E, additional, Hotchkiss, R S, additional, and Coopersmith, C M, additional
- Published
- 2004
- Full Text
- View/download PDF
18. GUT EPITHELIAL APOPTOSIS OCCURS VIA THE MITOCHONDRIAL AND RECEPTOR-MEDIATED PATHWAYS IN STREPTOCOCCUS PNEUMONIAE PNEUMONIA.
- Author
-
Husain, K D, primary, Stromberg, P E, additional, Woolsey, C A, additional, Dunne, W M, additional, Buchman, T G, additional, Karl, I E, additional, Hotchkiss, R S, additional, and Coopersmith, C M, additional
- Published
- 2004
- Full Text
- View/download PDF
19. LUNG INJURY UNCOUPLES GUT APOPTOSIS AND PROLIFERATION
- Author
-
HUSAIN, K D, primary, STROMBERG, P E, additional, WOOLSEY, C A, additional, TURNBULL, I R, additional, BUCHMAN, T G, additional, KARL, I E, additional, HOTCHKISS, R S, additional, and COOPERSMITH, C M, additional
- Published
- 2004
- Full Text
- View/download PDF
20. EXOGENOUS IRON AFTER SEPSIS INCREASES MORTALITY AND ALTERS APOPTOSIS
- Author
-
JAVADI, P, primary, STROMBERG, P E, additional, HUSAIN, K D, additional, WOOLSEY, C A, additional, BUCHMAN, T G, additional, KARL, I E, additional, HOTCHKISS, R S, additional, and COOPERSMITH, C M, additional
- Published
- 2004
- Full Text
- View/download PDF
21. GUT OVER-EXPRESSION OF BCL-2 REQUIRES LYMPHOCYTES TO IMPROVE SURVIVAL
- Author
-
STROMBERG, P E, primary, CHANG, K C, additional, WOOLSEY, C W, additional, HOTCHKISS, W R, additional, BUCHMAN, T G, additional, KARL, I E, additional, HOTCHKISS, R S, additional, and COOPERSMITH, C M, additional
- Published
- 2004
- Full Text
- View/download PDF
22. LYMPHOCYTES ALTER GUT EPITHELIAL PROLIFERATION BUT NOT APOPTOSIS IN SEPSIS
- Author
-
Stromberq, P E, primary, Turnbull, I R, additional, Chang, K C, additional, Husain, K D, additional, Hotchkiss, R S, additional, Buchman, T G, additional, and Coopersmith, C M, additional
- Published
- 2003
- Full Text
- View/download PDF
23. BCL-2 INHIBITS GUT EPITHELIAL APOPTOSIS BUT DOES NOT IMPROVE SURVIVAL IN ACUTE LUNG INJURY.
- Author
-
Husain, K D, primary, Stromberg, P E, additional, Javadi, P, additional, DM, Amiot, additional, Buchman, T G, additional, Karl, I E, additional, Hotchkiss, R S, additional, and Coopersmith, C M, additional
- Published
- 2003
- Full Text
- View/download PDF
24. SEPSIS FROM PSEUDOMONAS AERUGINOSA PNEUMONIA INDUCES GUT EPITHELIAL CELL CYCLE ARREST.
- Author
-
Coopersmith, C. M., primary, Stromberg, P. E., additional, Davis, C. G., additional, Dunne, W. M., additional, Amiot, D. M., additional, Karl, I. E., additional, Hotchkiss, R. S., additional, and Buchman, T. G., additional
- Published
- 2002
- Full Text
- View/download PDF
25. SEPSIS CAUSES LOSS OF CD3 T CELLS, B CELLS, AND LYMPHOID FOLLICLES.
- Author
-
Tinsley, K, primary, Swanson, P, additional, Coopersmith, C, additional, Wagner, T, additional, Schmieg, R, additional, Chang, K, additional, Osborne, D, additional, Freeman, B, additional, Cobb, J, additional, Buchman, T, additional, Karl, I, additional, and Hotchkiss, R, additional
- Published
- 2001
- Full Text
- View/download PDF
26. Influence of paced mating and number of intromissions on fertility in the laboratory rat
- Author
-
Coopersmith, C., primary and Erskine, M. S., additional
- Published
- 1994
- Full Text
- View/download PDF
27. Expression of wild-type and mutant simian virus 40 large tumor antigens in villus-associated enterocytes of transgenic mice.
- Author
-
Kim, S H, primary, Roth, K A, additional, Coopersmith, C M, additional, Pipas, J M, additional, and Gordon, J I, additional
- Published
- 1994
- Full Text
- View/download PDF
28. Use of normal and transgenic mice to examine the relationship between terminal differentiation of intestinal epithelial cells and accumulation of their cell cycle regulators.
- Author
-
Chandrasekaran, C, Coopersmith, C M, and Gordon, J I
- Abstract
A spatially well organized continuum of proliferation, differentiation, and death is displayed along crypt-villus units in the adult mouse small intestine. This continuum provides an opportunity to examine in vivo the mechanisms by which proliferative status changes as a function of cellular differentiation. Immunohistochemical studies of normal FVB/N mice revealed that as epithelial cells complete their terminal differentiation during a 48-72-h migration up villi, there is a marked and rapid fall in the levels of two important regulators of the G1/S transition, cyclin D1 and cyclin-dependent kinase (cdk) 2. However, cellular levels of their partners, cdk4 and cyclin E, remain unchanged as does the level of pRB. Adult FVB/N transgenic mice were studied that contained an intestinal fatty acid binding protein gene promoter (Fabpi) linked to wild type Simian virus 40 large T antigen (SV40 TAgWt) or a mutant TAg with Lys for Glu substitutions at residues 107 and 108 (SV40 TAgK107/8) that fails to bind pRB and related pocket proteins. Both transgenes are expressed only in villus enterocytes. SV40 TAgWt causes these terminally differentiated cells to re-enter the cycle. Re-entry is accompanied by a reduction in un/hypophosphorylated pRB, an induction of cyclin D1 and cdk2, but no change in cdk4, cyclin E, or E2F-1. In contrast, SV40 TAgK107/8 fails to induce re-entry and does not produce changes in un/hypophosphorylated pRB, cyclin D1, or cdk2 accumulation. These results suggest that un/hypophosphorylated pRB is an important mediator of the cell cycle arrest that normally occurs as enterocytes exit the crypt and complete their differentiation. Fabpi-directed expression of E2F-1 does not cause villus enterocytes to return to the cell cycle, alter their suppression of cyclin D1 or cdk2, or affect their state of differentiation, emphasizing the insensitivity of these cells to the effects of E2F-1. Analyses of p53(-/-) and p53(+/+) mice containing Fabpi-SV40 TAgWt and Fabpi-SV40 TAgK107/8 established that the proliferation induced by SV40 TAgWt does not require p53 and is associated with increased (p53-independent) apoptosis. The presence of cyclin E and cdk4 in differentiating villus enterocytes emphasizes that these cells retain part of their proliferative heritage expressed 24-72 h earlier in the crypt. The data suggest that down-regulation of cdk2 and/or cyclin D1 expression may be important for control of proliferative status and/or execution of terminal differentiation.
- Published
- 1996
29. Effects of paced and non-paced mating stimulation on plasma progesterone, 3a-Diol and corticosterone
- Author
-
Frye, C. A., McCormick, C. M., Coopersmith, C., and Erskine, M. S.
- Published
- 1996
- Full Text
- View/download PDF
30. Epithelial apoptosis in mechanistically distinct methods of injury in the murine small intestine
- Author
-
Vyas, D., Robertson, C. M., Stromberg, P. E., Martin, J. R., Dunne, W. M., Houchen, C. W., Barrett, T. A., Ayala, A., Perl, M., Timothy Buchman, and Coopersmith, C. M.
- Subjects
616 - Patología. Medicina clínica. Oncología ,Apoptosis ,Intestine - Abstract
Gut epithelial apoptosis is involved in the pathophysiology of multiple diseases. This study characterized intestinal apoptosis in three mechanistically distinct injuries with different kinetics of cell death. FVB/N mice were subjected to gamma radiation, Pseudomonas aeruginosa pneumonia or injection of monoclonal anti-CD3 antibody and sacrificed 4, 12, or 24 hours post-injury (n=10/time point). Apoptosis was quantified in the jejunum by hematoxylin and eosin (H&E), active caspase-3, terminal deoxynucleotidyl transferase dUTP-mediated nick end labeling (TUNEL), in situ oligoligation reaction (ISOL,) cytokeratin 18, and annexin V staining. Reproducible results were obtained only for H&E, active caspase-3, TUNEL and ISOL, which were quantified and compared against each other for each injury at each time point. Kinetics of injury were different with early apoptosis highest following radiation, late apoptosis highest following anti CD3, and more consistent levels following pneumonia. ISOL was the most consistent stain and was always statistically indistinguishable from at least 2 stains. In contrast, active caspase-3 demonstrated lower levels of apoptosis, while the TUNEL assay had higher levels of apoptosis in the most severely injured intestine regardless of mechanism of injury. H&E was a statistical outlier more commonly mechanism or kinetics of injury, ISOL correlates to other quantification methods of detecting gut epithelial apoptosis more than any other method studied and compares favorably to other commonly accepted techniques of quantifying apoptosis in a large intestinal cross sectional by balancing sensitivity and specificity across a range of times and levels of death.
31. Environmental and Social Determinants of Fever in COVID-19
- Author
-
Bhavani, S., Edathara, N., Patrick Lyons, Luo, Y., Wiley, Z., Mao, C., Bewley, A., Robichaux, C., Verhoef, P. A., and Coopersmith, C.
32. A simple, low-cost oral care protocol reduces ventilator-associated pneumonia rates.
- Author
-
Sona C, Zack J, Schallom L, Schwartzkopf L, Huey W, Mcsweeney M, McMullen K, Mazuski J, Schuerer D, Coopersmith C, and Boyle W
- Published
- 2006
33. Surviving Sepsis Campaign Guidelines on the Management of Adults With Coronavirus Disease 2019 (COVID-19) in the ICU: First Update
- Author
-
Mark Crowther, Hannah Wunsch, Ryan Zarychanski, Massimo Antonelli, Daniel S. Chertow, Waleed Alhazzani, Muhammed Alshahrani, Greg S. Martin, Michelle N. Gong, Lennie P. G. Derde, Morten Hylander Møller, Frederick G. Hayden, Marlies Ostermann, Mitchell M. Levy, Wojciech Szczeklik, Younsuck Koh, Massimiliano Greco, Lisa Burry, Malgorzata M Bala, Naomi E Hammond, Simon Oczkowski, Andrew Rhodes, Bin Du, Ziad A. Memish, Laura Evans, Yaseen M. Arabi, Mark Loeb, Amy S. Arrington, Zainab Al Duhailib, Ruth M. Kleinpell, Craig M. Coopersmith, Kimberley Lewis, Lewis J. Kaplan, Amy L. Dzierba, Maurizio Cecconi, Eddy Fan, Leonard A. Mermel, Elizabeth Bridges, Giuseppe Citerio, Sheila Nainan Myatra, Flávia Ribeiro Machado, Allison McGeer, Jozef Kesecioglu, Fayez Alshamsi, Emilie P. Belley-Côté, Hallie C. Prescott, Manoj J. Mammen, Alhazzani, W, Evans, L, Alshamsi, F, Møller, M, Ostermann, M, Prescott, H, Arabi, Y, Loeb, M, Ng Gong, M, Fan, E, Oczkowski, S, Levy, M, Derde, L, Dzierba, A, Du, B, Machado, F, Wunsch, H, Crowther, M, Cecconi, M, Koh, Y, Burry, L, Chertow, D, Szczeklik, W, Belley-Cote, E, Greco, M, Bala, M, Zarychanski, R, Kesecioglu, J, Mcgeer, A, Mermel, L, Mammen, M, Nainan Myatra, S, Arrington, A, Kleinpell, R, Citerio, G, Lewis, K, Bridges, E, Memish, Z, Hammond, N, Hayden, F, Alshahrani, M, Al Duhailib, Z, Martin, G, Kaplan, L, Coopersmith, C, Antonelli, M, and Rhodes, A
- Subjects
Adult ,medicine.medical_specialty ,Surviving Sepsis Campaign ,Critical Care ,Coronavirus Disease 2019 (COVID-19) ,Guideline ,Critical Care and Intensive Care Medicine ,medicine.disease_cause ,Dexamethasone ,Patient Positioning ,03 medical and health sciences ,0302 clinical medicine ,Adrenal Cortex Hormones ,Pandemic ,medicine ,Humans ,Disease management (health) ,Intensive care medicine ,COVID-19 Serotherapy ,Coronavirus ,Alanine ,Evidence-Based Medicine ,business.industry ,Hemodynamics ,Immunization, Passive ,Anticoagulants ,COVID-19 ,Disease Management ,030208 emergency & critical care medicine ,Evidence-based medicine ,Adenosine Monophosphate ,Ventilation ,Clinical trial ,Intensive Care Units ,Systematic review ,030228 respiratory system ,Practice Guidelines as Topic ,ICU ,business ,Hydroxychloroquine - Abstract
BACKGROUND: The coronavirus disease 2019 pandemic continues to affect millions worldwide. Given the rapidly growing evidence base, we implemented a living guideline model to provide guidance on the management of patients with severe or critical coronavirus disease 2019 in the ICU. METHODS: The Surviving Sepsis Campaign Coronavirus Disease 2019 panel has expanded to include 43 experts from 14 countries; all panel members completed an electronic conflict-of-interest disclosure form. In this update, the panel addressed nine questions relevant to managing severe or critical coronavirus disease 2019 in the ICU. We used the World Health Organization's definition of severe and critical coronavirus disease 2019. The systematic reviews team searched the literature for relevant evidence, aiming to identify systematic reviews and clinical trials. When appropriate, we performed a random-effects meta-analysis to summarize treatment effects. We assessed the quality of the evidence using the Grading of Recommendations, Assessment, Development, and Evaluation approach, then used the evidence-to-decision framework to generate recommendations based on the balance between benefit and harm, resource and cost implications, equity, and feasibility. RESULTS: The Surviving Sepsis Campaign Coronavirus Diease 2019 panel issued nine statements (three new and six updated) related to ICU patients with severe or critical coronavirus disease 2019. For severe or critical coronavirus disease 2019, the panel strongly recommends using systemic corticosteroids and venous thromboprophylaxis but strongly recommends against using hydroxychloroquine. In addition, the panel suggests using dexamethasone (compared with other corticosteroids) and suggests against using convalescent plasma and therapeutic anticoagulation outside clinical trials. The Surviving Sepsis Campaign Coronavirus Diease 2019 panel suggests using remdesivir in nonventilated patients with severe coronavirus disease 2019 and suggests against starting remdesivir in patients with critical coronavirus disease 2019 outside clinical trials. Because of insufficient evidence, the panel did not issue a recommendation on the use of awake prone positioning. CONCLUSION: The Surviving Sepsis Campaign Coronavirus Diease 2019 panel issued several recommendations to guide healthcare professionals caring for adults with critical or severe coronavirus disease 2019 in the ICU. Based on a living guideline model the recommendations will be updated as new evidence becomes available.
- Published
- 2021
34. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016
- Author
-
Craig French, Daniel De Backer, Waleed Alhazzani, Ruth M. Kleinpell, Mitchell M. Levy, Dilip R. Karnad, B. Taylor Thompson, Marco Ranieri, Christopher W. Seymour, Lisa Shieh, Khalid A. Shukri, Anand Kumar, Lauralyn McIntyre, Alan E. Jones, Gordon D. Rubenfeld, Janice L. Zimmerman, Craig M. Coopersmith, Jean Louis Vincent, John E. Mazuski, Tiffany M. Osborn, Sean R. Townsend, Derek C. Angus, Steven Q. Simpson, Paolo Navalesi, Thiago Lisboa, John Myburgh, Gordon R. Bernard, Bram Rochwerg, Sangeeta Mehta, Herwig Gerlach, Charles L. Sprung, John J. Marini, Ricard Ferrer, W. Joost Wiersinga, Thomas Van der Poll, Laura Evans, Christa A. Schorr, Anthony S. McLean, Seitaro Fujishima, Flávia Ribeiro Machado, Steven M. Hollenberg, Maureen A. Seckel, Geoffrey J. Bellinghan, Colleen M. Plunkett, Osamu Nishida, John C. Marshall, Jean Daniel Chiche, Jorge Hidalgo, Andrew Rhodes, Richard Beale, Djillali Annane, Jonathan E. Sevransky, Rui Moreno, Mark E. Nunnally, Anders Perner, R. Phillip Dellinger, Mervyn Singer, Younsuck Koh, Massimo Antonelli, AII - Infectious diseases, Infectious diseases, Center of Experimental and Molecular Medicine, AII - Amsterdam institute for Infection and Immunity, Rhodes, A., Evans, L.E., Alhazzani, W., Levy, M.M., Antonelli, M., Ferrer, R., Kumar, A., Sevransky, J.E., Sprung, C.L., Nunnally, M.E., Rochwerg, B., Rubenfeld, G.D., Angus, D.C., Annane, D., Beale, R.J., Bellinghan, G.J., Bernard, G.R., Chiche, J.-D., Coopersmith, C., De Backer, D.P., French, C.J., Fujishima, S., Gerlach, H., Hidalgo, J.L., Hollenberg, S.M., Jones, A.E., Karnad, D.R., Kleinpell, R.M., Koh, Y., Lisboa, T.C., Machado, F.R., Marini, J.J., Marshall, J.C., Mazuski, J.E., McIntyre, L.A., McLean, A.S., Mehta, S., Moreno, R.P., Myburgh, J., Navalesi, P., Nishida, O., Osborn, T.M., Perner, A., Plunkett, C.M., Ranieri, M., Schorr, C.A., Seckel, M.A., Seymour, C.W., Shieh, L., Shukri, K.A., Simpson, S.Q., Singer, M., Thompson, B.T., Townsend, S.R., Van der Poll, T., Vincent, J.-L., Wiersinga, W.J., Zimmerman, J.L., Dellinger, R.P., MacHado, F.R., and Van Der Poll, T.
- Subjects
Shock, Septic, Anti-Bacterial Agent ,vancomycin ,fluid resuscitation ,high risk patient ,Critical Care and Intensive Care Medicine ,anticoagulant agent ,intensive care unit ,capillary blood ,Septic shock ,Medicine ,pulmonary artery catheter ,health care organization ,Nutritional Support ,beta 2 adrenergic receptor stimulating agent ,critical illne ,clinical trial ,Shock, Septic ,Renal Replacement Therapy ,Grading of Recommendations Assessment, Development, and Evaluation criteria ,priority journal ,risk factor ,health care quality ,nutritional assessment ,health care policy ,drug withdrawal ,standards, Anti-Bacterial Agent ,pyelonephriti ,survival rate ,medicine.medical_specialty ,Evidence-based medicine ,Sepsis bundle ,Sepsi ,Critical Illness ,Best practice ,fresh frozen plasma ,bicarbonate ,Development ,piperacillin plus tazobactam ,Article ,03 medical and health sciences ,ertapenem ,critically ill patient ,hemodynamic ,vascular access device ,Sepsis ,neuromuscular blocking agent ,Guidelines ,Infection ,Sepsis bundles ,Sepsis syndrome ,Surviving Sepsis Campaign ,cefepime ,mycosi ,neutropenia ,hydrocortisone ,education ,insulin treatment ,levofloxacin ,point of care testing ,anticoagulant therapy ,meta analysi ,funding ,screening ,dobutamine ,respiratory failure ,infection prevention ,noninvasive ventilation ,treatment response ,Guideline ,thrombomodulin ,glucose blood level ,Vasoconstrictor Agent ,Blood Glucose ,evidence based medicine ,thrombosis prevention ,histamine H2 receptor antagonist ,virus infection ,Vasoconstrictor Agents ,intensive care ,artificial ventilation ,adult respiratory distress syndrome ,Development and Evaluation criteria ,infection control ,assessment of human ,stress ulcer ,sedation ,purification ,Critical Care ,noradrenalin ,cohort analysi ,MEDLINE ,doripenem ,parenteral nutrition ,carbapenem ,high frequency ventilation ,blood ,epinephrine ,pharmacokinetic parameter ,hypertensive agent ,supine position ,business.industry ,fluid balance ,penicillin derivative ,Nutrition Assessment ,antiinfective agent, abdominal infection ,patient care planning ,resuscitation ,Review ,0302 clinical medicine ,meropenem ,prokinetic agent ,consensu ,antibiotic therapy ,antibiotic agent ,colistin ,education.field_of_study ,low molecular weight heparin ,creatinine ,consensus development ,pulmonary artery catheterization ,hypertensive factor ,anemia ,and Evaluation criteria ,antiinfective agent ,antithrombin ,erythropoietin ,dopamine ,Human ,insulin ,corticosteroid ,teleconference ,erythrocyte transfusion ,proton pump inhibitor ,drug combination ,omega 3 fatty acid ,gastrointestinal hemorrhage ,cilastatin plus imipenem ,fluid therapy ,Settore MED/41 - ANESTESIOLOGIA ,unindexed drug ,Humans ,bacteremia ,lactic acidemia ,Intensive care medicine ,hypoxemia ,treatment duration ,practice guideline ,cephalosporin derivative ,medicine.disease ,mortality ,Respiration, Artificial ,ceftriaxone ,immunoglobulin ,vasopressin ,artery catheter ,heparin ,Grading of Recommendations Assessment ,low drug dose ,calcitonin ,030212 general & internal medicine ,randomized controlled trial (topic) ,glucose ,pharmacokinetic ,electronic medical record ,teicoplanin ,evidence based practice ,analgesia ,analgesic agent ,drotrecogin ,Anti-Bacterial Agents ,Intensive Care Units ,drug contraindication ,positive end expiratory pressure ,bronchospasm ,DOPA ,blood sampling ,oliguria ,procalcitonin ,heart muscle ischemia ,thrombocyte transfusion ,conflict of interest ,Population ,venous thromboembolism ,vascular acce ,dalteparin ,ciprofloxacin ,acute kidney failure ,renal protection ,030208 emergency & critical care medicine ,vasoconstrictor agent, acute kidney failure ,immune deficiency ,bleeding ,pharmacodynamic ,crystalloid ,hemoglobin determination ,business ,Grading of Recommendations Assessment Development and Evaluation system ,arterial blood - Abstract
Objective: To provide an update to "Surviving Sepsis Campaign Guidelines for Management of Sepsis and Septic Shock: 2012." Design: A consensus committee of 55 international experts representing 25 international organizations was convened. Nominal groups were assembled at key international meetings (for those committee members attending the conference). A formal conflict-of-interest (COI) policy was developed at the onset of the process and enforced throughout. A stand-alone meeting was held for all panel members in December 2015. Teleconferences and electronic-based discussion among subgroups and among the entire committee served as an integral part of the development. Methods: The panel consisted of five sections: hemodynamics infection adjunctive therapies metabolic and ventilation. Population, intervention, comparison, and outcomes (PICO) questions were reviewed and updated as needed, and evidence profiles were generated. Each subgroup generated a list of questions, searched for best available evidence, and then followed the principles of the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) system to assess the quality of evidence from high to very low, and to formulate recommendations as strong or weak, or best practice statement when applicable. Results: The Surviving Sepsis Guideline panel provided 93 statements on early management and resuscitation of patients with sepsis or septic shock. Overall, 32 were strong recommendations, 39 were weak recommendations, and 18 were best-practice statements. No recommendation was provided for four questions. Conclusions: Substantial agreement exists among a large cohort of international experts regarding many strong recommendations for the best care of patients with sepsis. Although a significant number of aspects of care have relatively weak support, evidence-based recommendations regarding the acute management of sepsis and septic shock are the foundation of improved outcomes for these critically ill patients with high mortality. © 2016 by the Society of Critical Care Medicine and Wolters Kluwer Health, Inc. All Rights Reserved.
- Published
- 2017
35. National Institutes of Health COVID-19 Treatment Guidelines Panel: Perspectives and Lessons Learned.
- Author
-
Gulick RM, Pau AK, Daar E, Evans L, Gandhi RT, Tebas P, Ridzon R, Masur H, Lane HC, Adimora AA, Baker J, Kreuziger LB, Bedimo R, Belperio P, Bhalla A, Burgess T, Campbell D, Cantrill S, Chew K, Chiotos K, Coopersmith C, Davey R, Dzierba A, Eisnor D, Eschenauer G, Francis J, Gallagher J, Glidden D, Goldenberg N, Grund B, Han A, Hardy E, Harrison C, Henderson L, Higgs E, Hinkson C, Hughes B, Johnson S, Keller M, Kim A, Knight R, Kuriakose S, Lennox J, Lerner A, Levy M, Li J, MacBrayne C, Martin G, Nadig N, Nason M, Patel P, Pavia A, Proschan M, Schulert G, Seam N, Sheikh V, Simpson S, Singh K, Swindells S, Tien P, Uyeki T, Waghmare A, Wolfe C, Yazdany J, and Aberg J
- Subjects
- Humans, United States, COVID-19 Drug Treatment, Antiviral Agents therapeutic use, COVID-19 therapy, National Institutes of Health (U.S.), SARS-CoV-2, Practice Guidelines as Topic
- Abstract
Description: In March 2020, the White House Coronavirus Task Force determined that clinicians in the United States needed expert treatment guidelines to optimally manage patients with COVID-19, a potentially life-threatening disease caused by a new pathogen for which no specific treatments were known to be effective., Methods: The U.S. Department of Health and Human Services requested that the National Institutes of Health (NIH) take the lead in expeditiously convening a panel of experts to create "living" guidelines that would be widely accessible and capable of frequent updating as important new information became available., Recommendations: The purpose of this article is to expand on the experiences of the NIH COVID-19 Treatment Guidelines Panel (the Panel) over the past 4 years, summarize the Panel's final recommendations for COVID-19, highlight some challenges and unanswered questions about COVID-19 management, and inform future responses to public health emergencies. The Panel was formed in March 2020, and the first iteration of the guidelines was released in April 2020. Now that the public health emergency has ended, the NIH COVID-19 Treatment Guidelines have sunsetted. This role will now fall to professional societies and organizations, such as the American College of Physicians, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the World Health Organization, all of which have been active in this area., Competing Interests: Disclosures: Disclosure forms are available with the article online.
- Published
- 2024
- Full Text
- View/download PDF
36. Convalescent Plasma for the Treatment of COVID-19: Perspectives of the National Institutes of Health COVID-19 Treatment Guidelines Panel.
- Author
-
Pau AK, Aberg J, Baker J, Belperio PS, Coopersmith C, Crew P, Grund B, Gulick RM, Harrison C, Kim A, Lane HC, Masur H, Sheikh V, Singh K, Yazdany J, and Tebas P
- Subjects
- Humans, Immunization, Passive methods, National Institutes of Health (U.S.), SARS-CoV-2, United States, COVID-19 Serotherapy, COVID-19 immunology, COVID-19 therapy, Plasma immunology
- Published
- 2021
- Full Text
- View/download PDF
37. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016.
- Author
-
Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R, Kumar A, Sevransky JE, Sprung CL, Nunnally ME, Rochwerg B, Rubenfeld GD, Angus DC, Annane D, Beale RJ, Bellinghan GJ, Bernard GR, Chiche JD, Coopersmith C, De Backer DP, French CJ, Fujishima S, Gerlach H, Hidalgo JL, Hollenberg SM, Jones AE, Karnad DR, Kleinpell RM, Koh Y, Lisboa TC, Machado FR, Marini JJ, Marshall JC, Mazuski JE, McIntyre LA, McLean AS, Mehta S, Moreno RP, Myburgh J, Navalesi P, Nishida O, Osborn TM, Perner A, Plunkett CM, Ranieri M, Schorr CA, Seckel MA, Seymour CW, Shieh L, Shukri KA, Simpson SQ, Singer M, Thompson BT, Townsend SR, Van der Poll T, Vincent JL, Wiersinga WJ, Zimmerman JL, and Dellinger RP
- Subjects
- Anti-Bacterial Agents administration & dosage, Anti-Bacterial Agents therapeutic use, Blood Glucose, Calcitonin blood, Critical Illness therapy, Erythrocyte Transfusion, Fluid Therapy, Humans, Nutrition Assessment, Patient Care Planning, Renal Replacement Therapy, Respiration, Artificial, Sepsis diagnosis, Shock, Septic diagnosis, Shock, Septic therapy, Vasoconstrictor Agents therapeutic use, Sepsis therapy
- Abstract
Objective: To provide an update to "Surviving Sepsis Campaign Guidelines for Management of Sepsis and Septic Shock: 2012"., Design: A consensus committee of 55 international experts representing 25 international organizations was convened. Nominal groups were assembled at key international meetings (for those committee members attending the conference). A formal conflict-of-interest (COI) policy was developed at the onset of the process and enforced throughout. A stand-alone meeting was held for all panel members in December 2015. Teleconferences and electronic-based discussion among subgroups and among the entire committee served as an integral part of the development., Methods: The panel consisted of five sections: hemodynamics, infection, adjunctive therapies, metabolic, and ventilation. Population, intervention, comparison, and outcomes (PICO) questions were reviewed and updated as needed, and evidence profiles were generated. Each subgroup generated a list of questions, searched for best available evidence, and then followed the principles of the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) system to assess the quality of evidence from high to very low, and to formulate recommendations as strong or weak, or best practice statement when applicable., Results: The Surviving Sepsis Guideline panel provided 93 statements on early management and resuscitation of patients with sepsis or septic shock. Overall, 32 were strong recommendations, 39 were weak recommendations, and 18 were best-practice statements. No recommendation was provided for four questions., Conclusions: Substantial agreement exists among a large cohort of international experts regarding many strong recommendations for the best care of patients with sepsis. Although a significant number of aspects of care have relatively weak support, evidence-based recommendations regarding the acute management of sepsis and septic shock are the foundation of improved outcomes for these critically ill patients with high mortality.
- Published
- 2017
- Full Text
- View/download PDF
38. The workforce crisis: a functioning solution.
- Author
-
Buchman T, Grabenkort R, Coopersmith C, Meissen H, and Gregg S
- Subjects
- Humans, Workforce, Critical Care, Health Care Rationing standards, Health Services Needs and Demand, Intensive Care Units, Physicians supply & distribution, Quality Assurance, Health Care standards
- Published
- 2015
- Full Text
- View/download PDF
39. Epithelial apoptosis in mechanistically distinct methods of injury in the murine small intestine.
- Author
-
Vyas D, Robertson CM, Stromberg PE, Martin JR, Dunne WM, Houchen CW, Barrett TA, Ayala A, Perl M, Buchman TG, and Coopersmith CM
- Subjects
- Animals, Apoptosis radiation effects, CD3 Complex immunology, Caspase 3 metabolism, Gamma Rays adverse effects, In Situ Nick-End Labeling, Intestinal Mucosa injuries, Intestinal Mucosa radiation effects, Intestine, Small injuries, Intestine, Small radiation effects, Keratin-18 metabolism, Male, Mice, Pneumonia, Bacterial complications, Pseudomonas Infections complications, Sensitivity and Specificity, Sepsis complications, Stress, Mechanical, Apoptosis physiology, Immunohistochemistry methods, Intestinal Mucosa pathology, Intestine, Small pathology
- Abstract
Gut epithelial apoptosis is involved in the pathophysiology of multiple diseases. This study characterized intestinal apoptosis in three mechanistically distinct injuries with different kinetics of cell death. FVB/N mice were subjected to gamma radiation, Pseudomonas aeruginosa pneumonia or injection of monoclonal anti-CD3 antibody and sacrificed 4, 12, or 24 hours post-injury (n=10/time point). Apoptosis was quantified in the jejunum by hematoxylin and eosin (H&E), active caspase-3, terminal deoxynucleotidyl transferase dUTP-mediated nick end labeling (TUNEL), in situ oligoligation reaction (ISOL,) cytokeratin 18, and annexin V staining. Reproducible results were obtained only for H&E, active caspase-3, TUNEL and ISOL, which were quantified and compared against each other for each injury at each time point. Kinetics of injury were different with early apoptosis highest following radiation, late apoptosis highest following anti CD3, and more consistent levels following pneumonia. ISOL was the most consistent stain and was always statistically indistinguishable from at least 2 stains. In contrast, active caspase-3 demonstrated lower levels of apoptosis, while the TUNEL assay had higher levels of apoptosis in the most severely injured intestine regardless of mechanism of injury. H&E was a statistical outlier more commonly than any other stain. This suggests that regardless of mechanism or kinetics of injury, ISOL correlates to other quantification methods of detecting gut epithelial apoptosis more than any other method studied and compares favorably to other commonly accepted techniques of quantifying apoptosis in a large intestinal cross sectional by balancing sensitivity and specificity across a range of times and levels of death.
- Published
- 2007
- Full Text
- View/download PDF
40. Depletion of dendritic cells, but not macrophages, in patients with sepsis.
- Author
-
Hotchkiss RS, Tinsley KW, Swanson PE, Grayson MH, Osborne DF, Wagner TH, Cobb JP, Coopersmith C, and Karl IE
- Subjects
- Adolescent, Adult, Aged, Antigens, CD analysis, Antigens, CD immunology, Antigens, Differentiation, Myelomonocytic analysis, Antigens, Differentiation, Myelomonocytic immunology, Apoptosis, Female, Histocompatibility Antigens Class II analysis, Histocompatibility Antigens Class II immunology, Humans, Immunohistochemistry, Lipopolysaccharide Receptors analysis, Lipopolysaccharide Receptors immunology, Male, Middle Aged, Receptors, Complement 3d analysis, Receptors, Complement 3d immunology, Sepsis diagnosis, Spleen immunology, Dendritic Cells immunology, Macrophages immunology, Sepsis immunology
- Abstract
Dendritic cells (DCs) are a group of APCs that have an extraordinary capacity to interact with T and B cells and modulate their responses to invading pathogens. Although a number of defects in the immune system have been identified in sepsis, few studies have examined the effect of sepsis on DCs, which is the purpose of this study. In addition, this study investigated the effect of sepsis on macrophages, which are reported to undergo apoptosis, and MHC II expression, which has been noted to be decreased in sepsis. Spleens from 26 septic patients and 20 trauma patients were evaluated by immunohistochemical staining. Although sepsis did not decrease the number of macrophages, sepsis did cause a dramatic reduction in the percentage area of spleen occupied by FDCs, i.e., 2.9 +/- 0.4 vs 0.7 +/- 0.2% in trauma and septic patients, respectively. The number of MHC II-expressing cells, including interdigitating DCs, was decreased in septic, compared with trauma, patients. However, sepsis did not appear to induce a loss of MHC II expression in those B cells, macrophages, or DCs that were still present. The dramatic loss of DCs in sepsis may significantly impair B and T cell function and contribute to the immune suppression that is a hallmark of the disorder.
- Published
- 2002
- Full Text
- View/download PDF
41. Appetitive and consummatory sexual behaviors of female rats in bilevel chambers. I. A correlational and factor analysis and the effects of ovarian hormones.
- Author
-
Pfaus JG, Smith WJ, and Coopersmith CB
- Subjects
- Animals, Copulation drug effects, Ejaculation physiology, Estrogens pharmacology, Female, Housing, Animal, Male, Motor Activity physiology, Orchiectomy, Ovariectomy, Progesterone pharmacology, Rats, Rats, Long-Evans, Brain Chemistry physiology, Copulation physiology, Motivation, Posture physiology
- Abstract
This study investigated measures of sexual behavior displayed by female rats in bilevel chambers, the statistical relationships among the measures, and their dependency on hormone priming. Normative data from a standard 35-min test of sexual behavior were gathered from 82 fully primed sexually experienced Long-Evans females and subjected to multiple correlational and factor analyses. Several consummatory measures of copulation were related significantly, whereas appetitive level changing was statistically independent of consummatory measures. Factor analyses were conducted using orthogonal rotations of correlational matrices derived either from (a) measures of female behavior alone or (b) measures of female and male behavior together. The first analysis revealed five factors that accounted for 84% of the intersubject variance: Receptivity, Pacing, Appetitive Level Changing, Lordosis Reflex, and Solicitation. The second factor analysis with male data included revealed seven factors that accounted for 95% of the intersubject variance: Pacing, Copulatory Rate, Mount Count, Receptivity, Appetitive Level Changing, Solicitation, and Lordosis Reflex. Subsequently, subsets of these females were maintained on different steroid priming regimens (oil, low estrogen, high estrogen, high estrogen and progesterone) prior to a standard test of sexual behavior. Although the expression of all sexual behaviors required estrogen priming, appetitive level changing, solicitation, and pacing required progesterone for their full expression. Finally, appetitive level changing developed following hormone treatment alone, regardless of whether the females received access to sexually active males, inactive castrated males, or other females. Use of bilevel chambers allows complex patterns of sexual behavior to be observed in female rats and may thus facilitate the identification of neurochemical or endocrine mechanisms associated with different aspects of female sexual motivation and performance., (Copyright 1999 Academic Press.)
- Published
- 1999
- Full Text
- View/download PDF
42. Unusual presentations of nonmycotic hepatic artery pseudoaneurysms after liver transplantation.
- Author
-
Lowell JA, Coopersmith CM, Shenoy S, and Howard TK
- Subjects
- Adult, Aneurysm, False etiology, Aneurysm, False surgery, Female, Humans, Male, Middle Aged, Postoperative Complications etiology, Postoperative Complications surgery, Retrospective Studies, Aneurysm, False diagnosis, Hepatic Artery, Liver Transplantation, Postoperative Complications diagnosis
- Abstract
The clinical presentation and causes of hepatic artery pseudoaneurysm vary widely in the postoperative liver transplant recipient, although infection is the most common cause. Although uncommon, hepatic artery complications continue to be an important source of morbidity in liver transplant recipients. Thrombosis, stenosis, and pseudoaneurysm formation are the most common posttransplantation arterial complications. Pseudoaneurysms are most commonly mycotic in origin. Prompt recognition of hepatic artery pseudoaneurysms with aggressive intervention (both surgical and angiographic) may decrease the morbidity associated with this rare clinical entity. The records of 263 consecutive patients who underwent orthotopic liver transplantation between 1991 and 1996 were reviewed retrospectively and assessed for hepatic artery complications. Two patients (0.7%) developed hepatic artery pseudoaneurysm, neither associated with infection. Both patients required operative repair and are doing well without vascular complications at a mean follow-up of 22.5 months. The clinical presentation and causes of hepatic artery pseudoaneurysm vary widely in the postoperative liver transplant recipient. Prompt recognition of hepatic artery pseudoaneurysms with aggressive intervention (both surgical and angiographic) may decrease the morbidity associated with this rare clinical entity.
- Published
- 1999
- Full Text
- View/download PDF
43. Bcl-2 inhibits ischemia-reperfusion-induced apoptosis in the intestinal epithelium of transgenic mice.
- Author
-
Coopersmith CM, O'Donnell D, and Gordon JI
- Subjects
- Animals, Gamma Rays, Homeostasis physiology, Intestinal Mucosa pathology, Intestinal Mucosa radiation effects, Ischemia physiopathology, Jejunum metabolism, Jejunum pathology, Mice, Mice, Inbred C57BL, Reperfusion Injury physiopathology, Tumor Suppressor Protein p53 physiology, Apoptosis physiology, Intestinal Mucosa blood supply, Ischemia pathology, Mice, Transgenic genetics, Proto-Oncogene Proteins c-bcl-2 genetics, Proto-Oncogene Proteins c-bcl-2 physiology, Reperfusion Injury pathology
- Abstract
Little is known about the effects of ischemia-reperfusion on the inductive, commitment, or execution phases of apoptosis. We have created a genetically defined model to study the response of small intestinal epithelial cells to ischemia-reperfusion injury as a function of their proliferative status and differentiation. Occlusion of the superior mesenteric artery for 20 min in adult FVB/N or C57BL/6 mice results in the appearance of TUNEL-positive apoptotic cells in the jejunal epithelium within 4 h, with a maximum response occurring at 24 h. Stimulation of apoptosis is greater in postmitotic, differentiated epithelial cells located in the upper portions of villi compared with undifferentiated, proliferating cells in the crypts of Lieberkühn (7-fold vs. 2-fold relative to sham-operated controls). Comparisons of p53(+/+) and p53(-/-) mice established that the apoptosis is p53 independent. To further characterize this response, we generated FVB/N transgenic mice that express human Bcl-2 in epithelial cells distributed from the base of crypts to the tips of their associated villi. The fivefold elevation in steady-state Bcl-2 concentration is not accompanied by detectable changes in the levels or cellular distributions of the related anti-apoptotic regulator Bcl-xL or of the proapoptotic regulators Bax and Bak and does not produce detectable effects on basal proliferation, differentiation, or death programs. The apoptotic response to ischemia-reperfusion is reduced twofold in the crypts and villi of transgenic mice compared with their normal littermates. These results suggest that both undifferentiated and differentiated cells undergo a commitment phase that is sensitive to Bcl-2. Forced expression of Bcl-2 also suppressed the p53-dependent death that occurs in proliferating crypt epithelial cells following gamma-irradiation. Thus suppressibility by Bcl-2 operationally defines a common feature of the apoptosis induced in the crypt epithelium by these two stimuli.
- Published
- 1999
- Full Text
- View/download PDF
44. Surgery of the small intestine.
- Author
-
Coopersmith CM and Lowell JA
- Abstract
This article reviews both clinical and scientific advances in surgery of the small intestine that have been reported in the last year. The management of both pediatric and adult intussusception is considered. Multiple studies on the evolving role of ileal pouch-anal anastomosis are assessed. The treatment and epidemiology of a wide variety of intestinal neoplasms are reviewed. Advances in small bowel transplantation are also reported. The cause of small bowel obstruction is considered as well as new strategies to prevent adhesion formation. Finally, a number of diverse topics relating to intestinal surgery, including new data on laparoscopic surgery, treatment of enterocutaneous fistulas, reconstruction after total gastrectomy, intestinal transit after ileocecal segment transposition, and ischemia/reperfusion and anastomotic healing, are reviewed.
- Published
- 1999
- Full Text
- View/download PDF
45. Pregnancy block in house mice (Mus domesticus) as a function of t-complex genotype: examination of the mate choice and male infanticide hypotheses.
- Author
-
Coopersmith CB and Lenington S
- Subjects
- Animals, Arousal genetics, Female, Genetic Carrier Screening, Male, Pregnancy, Social Environment, Testicular Hormones genetics, Ubiquitin-Protein Ligases, t-Complex Genome Region, Abortion, Veterinary genetics, Aggression, Genotype, Intracellular Signaling Peptides and Proteins, Mice genetics, Microtubule-Associated Proteins, Nuclear Proteins genetics, Pregnancy, Animal genetics
- Abstract
Pregnancy block, whereby recently mated female mice abort their pregnancies when exposed to novel (strange) males, was studied in house mice (Mus domesticus) differing in t-complex genotype; t-mutations are deleterious and +/t females avoid +/t males as mates. The results of Experiment 1, in which the genotype of the female, stud male, and strange male was systematically varied, showed that pregnancy block was most frequent when the strange male was +/+. Because this effect was not enhanced among +/t females when stud males were +/t, the results cannot clearly be explained by the hypothesis that pregnancy block is a manifestation of mate choice. Moreover, the "strange male" effect in Experiment 1 is unlikely to be a female response correlated with the risk of male infanticide, as +/+ and +/t males did not differ in their infanticidal tendencies (Experiments 2 & 3). Alternative hypotheses, including a modified version of the mate choice hypothesis, are discussed.
- Published
- 1998
- Full Text
- View/download PDF
46. Bi-transgenic mice reveal that K-rasVal12 augments a p53-independent apoptosis when small intestinal villus enterocytes reenter the cell cycle.
- Author
-
Coopersmith CM, Chandrasekaran C, McNevin MS, and Gordon JI
- Subjects
- Animals, Antigens, Polyomavirus Transforming genetics, Antigens, Polyomavirus Transforming metabolism, Female, Humans, Integrins metabolism, Intestine, Small metabolism, Intestine, Small pathology, Jejunum cytology, Jejunum metabolism, Ligands, Male, Membrane Proteins metabolism, Mice, Mice, Inbred C57BL, Mice, Transgenic, Protein Serine-Threonine Kinases metabolism, Proto-Oncogene Proteins metabolism, Proto-Oncogene Proteins c-bcl-2 metabolism, Proto-Oncogene Proteins c-raf, bcl-2 Homologous Antagonist-Killer Protein, bcl-2-Associated X Protein, bcl-X Protein, Apoptosis, Cell Cycle, Genes, ras, Intestine, Small cytology, Tumor Suppressor Protein p53
- Abstract
Studies in cell culture systems have indicated that oncogenic forms of Ras can affect apoptosis. Activating mutations of Ras occur in approximately 30% of all human tumors and 50% of colorectal carcinomas. Since these mutations appear at early or intermediate stages in multistep journeys to neoplasia, an effect on apoptosis may help determine whether initiated cells progress towards a more neoplastic state. We have tested the effects of K-rasVal12 on apoptosis in transgenic mice. A lineage-specific promoter was used to direct expression of human K-rasVal12, with or without wild-type (wt) or mutant SV-40 T antigens (TAg), in postmitotic villus enterocytes, the principal cell type of the small intestinal epithelium. Enterocytes can be induced to reenter the cell cycle by TAgWt. Reentry is dependent upon the ability of TAg to bind pRB and is associated with a p53-independent apoptosis. Analyses of K-rasVal12 x TAgWt bi-transgenic animals indicated that K-rasVal12 can enhance this apoptosis threefold but only in cycling cells; increased apoptosis does not occur when K-rasVal12 is expressed alone or with a TAg containing Glu107,108two head right arrow Lys107, 108 substitutions that block its ability to bind pRB. Analysis of bi-transgenic K-rasVal12 x TAgWt mice homozygous for wild-type or null p53 alleles established that the enhancement of apoptosis occurs through a p53-independent mechanism, is not attributable to augmented proliferation or to an increase in abortive cell cycle reentry (compared to TAgWt mice), and is not associated with detectable changes in the crypt-villus patterns of expression of apoptotic regulators (Bcl-2, Bcl-xL, Bak, and Bax) or mediators of epithelial cell-matrix interactions and survival (e.g., alpha5beta1 integrin and its ligand, fibronectin). Coexpression of K-rasVal12 and TAgWt produces dysplasia. The K-rasVal12-augmented apoptosis is unrelated to this dysplasia; enhanced apoptosis is also observed in cycling nondysplastic enterocytes that produce K-rasVal12 and a TAg with a COOH-terminal truncation. The dysplastic epithelium of K-rasVal12 x TAgWt mice does not develop neoplasms. Our results are consistent with this finding: (a) When expressed in initiated enterocytes with a proliferative abnormality, K-rasVal12 facilitates progression to a dysplastic phenotype; (b) by diminishing cell survival on the villus, the oncoprotein may impede further progression; and (c) additional mutations may be needed to suppress this proapoptotic response to K-rasVal12.
- Published
- 1997
- Full Text
- View/download PDF
47. gamma-Ray-induced apoptosis in transgenic mice with proliferative abnormalities in their intestinal epithelium: re-entry of villus enterocytes into the cell cycle does not affect their radioresistance but enhances the radiosensitivity of the crypt by inducing p53.
- Author
-
Coopersmith CM and Gordon JI
- Subjects
- Animals, Cell Cycle, Gamma Rays, Intestines cytology, Mice, Mice, Inbred C57BL, Mice, Transgenic, Apoptosis radiation effects, Intestines radiation effects, Radiation Tolerance, Tumor Suppressor Protein p53 physiology
- Abstract
The radiosensitivity of proliferating crypt epithelial cells makes the gut a major limiting factor in the use of radiotherapy for treatment of abdominal cancers. As post-mitotic epithelial cells migrate from mouse small intestinal crypts to the base of adjacent villi, they rapidly lose their ability to undergo apoptosis in response to ionizing irradiation (IR). To determine whether this radioresistance reflects withdrawal from the cell cycle, we used a lineage-specific promoter to direct expression of wild type Simian virus 40 T antigen (SV40 TAg(Wt)) to villus, but not crypt, enterocytes in FVB/N transgenic mice. SV40 TAg(Wt) induced, pRB-dependent, re-entry into the cell cycle is not associated with the acquisition of IR-stimulated apoptosis 4 h or 24 h after 6 Gy or 12 Gy of gamma-irradiation. Co-expression of SV40 TAg(Wt) and K-ras(val12) produces dysplasia in cycling villus enterocytes but no shift towards apoptotic responsiveness to IR. These findings suggest that the radioresistance of villus enterocytes is not simply due to their cell cycle arrest and may be a reflection of their microenvironment. Remarkably, reentry of villus enterocytes to the cell cycle increases the radiosensitivity of the crypt epithelium without changing Bcl-2, Bcl-xL, Bak, or Bax expression. This effect is only manifest after IR and, based upon results obtained with mutant SV40 TAgs, depends upon reaching a critical level of proliferation in villus enterocytes. Like the normal crypt response to IR, the villus-derived enhancement of IR-stimulated crypt apoptosis is associated with an induction of p53 and Raf-1, and is dependent upon p53. Unlike the normal crypt response to IR, the p53 induction involves cells distributed throughout the crypt and the apoptotic response is not confined to the lower half of the crypt. These results indicate that signals initiated by cycling enterocytes can be transmitted to the crypt epithelium to induce p53 and influence their IR-induced apoptosis. Understanding the underlying signaling pathways may provide clues about how to modify a normal crypt's radiosensitivity for therapeutic benefit.
- Published
- 1997
- Full Text
- View/download PDF
48. Effects of paced mating and intromissive stimulation on feminine sexual behavior and estrus termination in the cycling rat.
- Author
-
Coopersmith C, Candurra C, and Erskine MS
- Subjects
- Animals, Choice Behavior, Female, Male, Rats, Copulation, Estrus psychology, Motivation, Sexual Behavior, Animal
- Abstract
The effects of differential mating stimulation on sexual behavior and estrus length were examined in cycling rats that could or could not self-regulate, or pace, the timing of sexual contact. Female rats (Rattus norvegicus) received 30 paced, 30 nonpaced, or 15 nonpaced followed by 15 paced intromissions during mating tests. Decreases in sexual responsiveness were seen during the second half of testing; pacing was associated with greater inter-intromission intervals, decreased proceptivity, and increased rejection behavior at this time. Female rats pacing during the second test half behaved similarly, regardless of prior treatment, showing that the number rather than the timing of prior intromissions affected subsequent behavior. However, estrus length was decreased by prior paced mating. These data suggest that changes in sexual responsivity occur throughout estrus and that the nature of these changes is differentially dependent on the type of mating stimulation received.
- Published
- 1996
- Full Text
- View/download PDF
49. Effects of paced and non-paced mating stimulation on plasma progesterone, 3 alpha-diol and corticosterone.
- Author
-
Frye CA, McCormick CM, Coopersmith C, and Erskine MS
- Subjects
- Animals, Ejaculation drug effects, Estradiol pharmacology, Female, Male, Ovariectomy, Posture physiology, Rats, Androstane-3,17-diol blood, Corticosterone blood, Progesterone blood, Sexual Behavior, Animal drug effects
- Abstract
In the female rat, gonadal and adrenal progestins and androgens modulate sexual receptivity and in turn, their levels increase in response to mating stimulation. Paced mating, in which the female controls the timing of sexual contacts with the male, is particularly effective at eliciting acute increases in progesterone (P) and 5 alpha-Androstane-3 alpha, 17 beta-diol (3 alpha-Diol). Interestingly, restraint stress produces comparable increases in P and 3 alpha-Diol levels, as well as increases in corticosterone (CORT) levels. In this study, we explored the possibility that paced mating would be associated with increased CORT, in conjunction with mating-induced increases in P and 3 alpha-Diol. Ovariectomized rats primed with estradiol benzoate (10 micrograms in oil SC) and P (0.5 mg in oil s.c.) received a single ejaculatory series from males in paced or non-paced mating tests. Fifteen minutes post-mating rats were exposed to CO2 and rapidly decapitated for the collection of trunk blood and determination of P, 3 alpha-Diol and CORT via radioimmunoassay. As expected, P and 3 alpha-Diol concentrations were significantly elevated in serum obtained from animals allowed to pace their sexual contacts with males compared to those which did not pace their contacts. Importantly, although all mated animals had CORT levels between 10-20 micrograms/dl, there were no differences between paced and non-paced conditions. This suggests that the acute rises in P and 3 alpha-Diol in response to paced mating are not due to paced mating being more stressful than non-paced mating.
- Published
- 1996
- Full Text
- View/download PDF
50. Infusions of lidocaine into the amygdala, but not the preoptic area, block pseudopregnancy in the rat.
- Author
-
Coopersmith C, Gans SE, Rowe DW, and Erskine MS
- Subjects
- Amygdala physiology, Animals, Calcium Channel Blockers pharmacology, Female, Lidocaine pharmacology, Male, Preoptic Area physiology, Rats, Verapamil administration & dosage, Verapamil pharmacology, Amygdala drug effects, Lidocaine administration & dosage, Preoptic Area drug effects, Pseudopregnancy physiopathology
- Abstract
In the rat, vaginocervical stimulation (VCS) received during mating is required for the subsequent expression of 10-12 days of twice-daily prolactin surges that are necessary for pregnancy or pseudopregnancy (PSP). This temporal separation of sensory stimulus and neuroendocrine response suggests that a mnemonic of the vaginocervical stimulation is created in the brain that triggers and sustains the daily prolactin surges. We investigated the possible involvement of the medial preoptic area (mPOA) and the medial amygdala (mAMYG) as potential neural sites involved in the processing of this neuroendocrine arc. Cycling female rats were bilaterally implanted with intracerebral cannulae in either the mPOA or mAMYG. On proestrus, females were manually palpated to confirm sexual receptivity and then received bilateral infusions of either the local anesthetic lidocaine, the Ca(++) channel blocker, verapamil, or phosphate-buffered saline (PBS) into either brain site before or both before and after receipt of 15 intromissions from an experienced male. Unmated control females received comparable infusions of lidocaine or verapamil, and were placed in the empty test arena for 10 min. Infusions consisted of either a single bilateral infusion 15 min before mating (Expt. 1), bilateral infusions both 15 min before and after mating (Expt. 2) or eight bilateral infusions separated by 30 min intervals spanning a period beginning 45 min before and ending 2 h 45 min after mating (Expt. 3). None of the lidocaine infusions into the mPOA prevented the establishment of PSP, and neither verapamil infusions into the mAMYG nor the shorter-term neural block (i.e. single or double lidocaine infusions) of the mAMYG prevented mating-induced PSP. However, the longer-term neural block (i.e. multiple lidocaine infusions) of the mAMYG significantly reduced the incidence of PSP. These data support previous findings that the mAMYG receives sensory input from VCS, and suggest that the mAMYG is a site at which a mnemonic of VCS is established.
- Published
- 1996
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.